Cover
Cover | Aug. 15, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Aug. 15, 2022 |
Entity File Number | 001-40536 |
Entity Registrant Name | Acurx Pharmaceuticals, Inc. |
Entity Central Index Key | 0001736243 |
Entity Tax Identification Number | 82-3733567 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 259 Liberty Avenue |
Entity Address, City or Town | Staten Island |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 10305 |
City Area Code | 917 |
Local Phone Number | 533-1469 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | ACXP |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |